Skip to main content

Amlodipine, Valsartan and Hydrochlorothiazide

NDC 65862-836 · Aurobindo Pharma Limited

Generic nameAmlodipine, Valsartan and Hydrochlorothiazide
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)AMLODIPINE BESYLATE, VALSARTAN, HYDROCHLOROTHIAZIDE
Strength10; 12.5; 160 mg/1; mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

65862-836-05 — 500 TABLET, FILM COATED in 1 BOTTLE (65862-836-05)

65862-836-30 — 30 TABLET, FILM COATED in 1 BOTTLE (65862-836-30)

65862-836-90 — 90 TABLET, FILM COATED in 1 BOTTLE (65862-836-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

65862-631 — Irbesartan and Hydrochlorothiazide, 65862-737 — Amlodipine and valsartan, 65862-738 — Amlodipine and valsartan, 65862-739 — Amlodipine and valsartan, 65862-740 — Amlodipine and valsartan, 65862-779 — Olmesartan Medoxomil and Hydrochlorothiazide, 65862-780 — Olmesartan Medoxomil and Hydrochlorothiazide, 65862-781 — Olmesartan Medoxomil and Hydrochlorothiazide, 65862-834 — Amlodipine, Valsartan and Hydrochlorothiazide, 65862-835 — Amlodipine, Valsartan and Hydrochlorothiazide, 65862-837 — Amlodipine, Valsartan and Hydrochlorothiazide, 65862-838 — Amlodipine, Valsartan and Hydrochlorothiazide, 65862-854 — Amlodipine and Olmesartan Medoxomil, 65862-855 — Amlodipine and Olmesartan Medoxomil, 65862-856 — Amlodipine and Olmesartan Medoxomil, 65862-857 — Amlodipine and Olmesartan Medoxomil, 65862-976 — Telmisartan and Hydrochlorothiazide, 65862-977 — Telmisartan and Hydrochlorothiazide, 65862-978 — Telmisartan and Hydrochlorothiazide, 66267-106 — Hydrochlorothiazide, +1568 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.